This is hypothesized due to the relatively lower expression of BCL-2 and increased expression of MCL-1 and BCL2-A1 (through upstream mutant KRAS) in M4/M5 AML [8,19,20,21,22,23,24] (Table 1). This evidence concerns the gene BCL2 and acute myeloid leukemia.